Tony Blairs Economic Blueprint Diagnosis on Point Prescription Under Fire Trump Expresses Dissatisfaction with Iran Nuclear Deal Talks Heightening Geopolitical Uncertainty Obsession Poised to Achieve Major Box Office Milestones This Weekend Kevin Warsh Faces Divided Fed as Inflation Pressures Complicate Rate Cut Debate April Private Payrolls Rise 109000 Exceeding Expectations ADP Report Signals Steady Labor Market Alberta Separatist Vote Could Reshape Canadas Energy Landscape DG Q1 2026 Earnings EPS Beats Estimates as Dollar General Surpasses Expectations Dole Q1 2026 Earnings EPS Misses Estimates Revenue Not Disclosed UIS Q1 2026 Earnings Strong EPS Surprise as Unisys Posts SmallerthanExpected Loss PPBT Q1 2025 Earnings Narrowing Losses and Pipeline Progress Drive Optimism PDS Biotechnology Q1 2026 Earnings EPS Beat and Clinical Progress Highlight PreRevenue Quarter ENPH Q1 2026 Earnings EPS Surprises to the Upside as Enphase Navigates Market Headwinds Day One Biopharmaceuticals DAWN Holds Steady Consolidation Near Support Tests Blend Labs BLND Surges Over 10 as Momentum Builds Near Key Resistance SolarEdge Technologies SEDG Surges 55 as Solar Sector Regains Lift Warby Parker WRBY Pushes Higher as Eyewear Retailer Tests Key Resistance BlackRock Science and Technology Trust BST Gains 231 as Tech Sentiment Lifts Prices Liberty Live Group LLYVA Holds Steady Near 96 as Support and Resistance Levels Come into Focus OneIM Acquisition Corp OIM Holds Steady at 1001 Low Volatility Signals Waiting Game Copa Holdings CPA Holds Steady Near Support Amid Minimal Volatility Core Scientific CORZ Gains 177 as Cryptocurrency Mining Sector Shows Renewed Momentum Titan Acquisition Corp Warrants TACHW Edge Higher Support Holds as Price Approaches Key Resistance Westin Acquisition Corp Units WSTNU Holds Steady at 1018 SPAC Units Show Minimal Daily Movement US Natural Gas Futures Decline as Weather Forecasts Signal Milder Early February Temperatures MDV Q1 2026 Earnings Industrial REIT Reports Deep Earnings Miss as Losses Sharply Exceed Estimates Zymeworks Inc ZYME Faces Selling Pressure as Shares Dip 240 Key Levels in Focus